ORAL CAVITY CANCER METASTATIC

ORAL CAVITY CANCER METASTATIC was reported 15 times

ORAL CAVITY CANCER METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimycobacterial [EPC] 1 0.0000
1 Oxazolidinone Antibacterial [EPC] 1 0.0000
2 Integrin Receptor Antagonist [EPC] 2 0.0000
3 Platinum-based Drug [EPC] 3 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
5 Microtubule Inhibitor [EPC] 1 0.0000
6 Endothelin Receptor Antagonist [EPC] 1 0.0000
7 Vitamin D [EPC] 1 0.0000
8 Vitamin B12 [EPC] 1 0.0000
9 Vitamin C [EPC] 1 0.0000
10 Insulin Analog [EPC] 1 0.0000
11 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
12 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
13 Corticosteroid [EPC] 1 0.0000